In addition to promoting cell death and senescence, p53 also has important cellular survival functions. A mutant p53, lacking a proline-rich domain (p53 ΔP ), that is deficient in controlling both cell death and cell cycle arrest, was employed to determine the biological means by which p53 mediates survival upon DNA damage. While p53 ΔP and p53 − / − cells were equally resistant to many DNA damaging agents, p53
P53 is one of the most frequently mutated genes in human tumors, and its proper activity and function is crucial for the maintenance of genomic stability and tumor suppression. 1 Although it remains undisputed that p53 is a potent suppressor of tumorigenesis, the biological means by which p53 prevents cellular transformation remains unclear. 2 To date, no ablation of a p53 target gene fully recapitulates the cancer predisposition of p53 null mice. [3] [4] [5] The long-held hypothesis in the field predicted that upon oncogene-induced cellular stress, cell cycle arrest or apoptosis was induced, thus allowing the cell time for efficient repair of the damage, or the elimination of cells that acquired irreparable damage. 6, 7 A genetic approach in which three p53 target genes required for cell cycle arrest and apoptosis were deleted, failed to phenocopy the spontaneous tumor incidence seen in p53 − / − mice. 8 However, given the requirement for p53 in the transcriptional regulation of hundreds of genes, it seems unlikely that the deletion of individual p53-mediated genes will produce a loss of tumor suppressor activity. [8] [9] [10] We used a genetic model in which the proline-rich domain (PRD) of p53 (p53 ΔP ) was deleted, resulting in an altered transcription function. 11 This mutant allowed us to evaluate the biological role of p53 that a majority of its target functions are ablated.
The PRD, defined by residues 58-98 and residues 62-91 of human and mouse p53 respectively, promotes p53-dependent transcription by an unclear mechanism. 12 Some studies suggest that deletion of this region changes the stability of p53 protein, as a consequence of diminished Pin1 binding resulting in increased susceptibility of p53 to MDM2-dependent degradation. Others suggest that the PRD instead mediates binding to cofactors important for efficient transcription. [13] [14] [15] [16] [17] [18] Nevertheless, deletion of the PRD of p53 (p53 ΔP (75-91); and mΔpro (58-88)) resulted in a loss of cell cycle arrest and apoptosis; yet mice lacking this region rarely develop spontaneous tumors seen in p53 − / − mice. 11, [19] [20] [21] [22] [23] The repair of DNA lesions is crucial to maintain genomic stability and p53 mediates the expression of numerous repair genes involved in nucleotide excision repair, base excision repair, mismatch repair, and non-homologous end joining. 24, 25 Mice with mutations or deletions in one of several DNA repair genes are prone to developing tumors. 26 Methylating agents, such as chemotherapies can modify DNA at many different sites, with the most mutagenic lesion being the alkylation of O 6 position of guanine (O 6 MeG). 27, 28 These lesions are highly mutagenic unless repaired, and fail to block DNA replication. [29] [30] [31] As a consequence, following two rounds of DNA replication these lesions manifest as G:C to A:T point mutations and represent a DNA adduct with the potential for tumor formation. 32 In some cases, A:T transitions have been shown to arise in the KRAS oncogene and p53 tumor suppressor gene, thus promoting tumorigenesis. [33] [34] [35] P53 induces the transcription of O6-methylguanine-DNA methyltransferase (MGMT), an enzyme that repairs O 6 MeG, via a one-step suicide reaction, involving the irreversible transfer of the methyl groups on the DNA lesion, to an internal cysteine residue in the active center of the alkyltransferase. [36] [37] [38] This reaction is stoichiometric involving one molecule of MGMT for each methyl group removed. 39 Following repair, MGMT is tagged by ubiquitin and degraded via the proteasome. 40, 41 While MGMT-deficient mice do not develop spontaneous tumors, they are highly vulnerable to oncogenesis induced by treatment with alkylating agents. [42] [43] [44] [45] [46] Conversely, mice with elevated MGMT expression levels exhibit resistance to alkylating agents and tumor formation. [47] [48] [49] This suggests that MGMT is important in tumor suppression.
We determined that p53 lacking the PRD failed to mediate the expression of key genes involved in apoptosis or cell cycle arrest. While cells harboring p53
ΔP were equally resistant to cell death induced by several DNA damaging agents as compared to p53
− / − cells, they surprisingly showed a greater resistance to high doses of the alkylating agent Diazald, than did p53
− / − cells. We determined that p53 ΔP was capable of transcribing the repair gene, MGMT and could thereby induce repair alkylating DNA damage, thus promoting p53
ΔP cell survival after alkylation damage.
Results
DNA damage-induced apoptosis and cell cycle arrest requires p53 with a functional proline-rich region. Since the proline-rich region of p53 is described to be essential for the efficient transcription function of p53, 12, 50 we first determined whether common target genes involved in apoptosis and cell cycle arrest were induced upon DNA damage in cells expressing p53 lacking a proline-rich region (p53 ΔP (75-91)). H1299 cells, that lack the p53 gene, were reconstituted with wild-type p53 (p53 WT ) or p53 lacking the proline-rich region (p53 ΔP ) fused to a modified estrogen receptor steroid-binding domain (ERTam) that binds 4-Hydroxytamoxifen (4OHT) specifically. Upon the addition of 4OHT for 5 h, both p21 and PUMA gene expression levels and protein levels were induced in cells expressing p53
WT , but not p53 ΔP (Figures 1a and c ). P21 and PUMA gene expression levels were also induced after 6 h in B cells treated with 5 Gy of irradiation isolated from p53 WT mice, but not those from p53 ΔP or p53 − / − mice ( Figure 1b ). E1A/RAS transformed mouse embryonic fibroblasts (MEF) from p53 WT , p53 ΔP , and p53 − / − mice were treated with a panel of DNA damage agents and assessed for Annexin V externalization after 18 h by flow cytometry. P53
WT -expressing MEF were sensitive to all DNA damaging agents tested, but p53
ΔP -expressing cells and p53
− / − cells were equally resistant to these death-inducing stimuli (Figure 1d ). In addition, p53
ΔP -expressing, and p53
− / − cells exhibited reduced cell cycle arrest upon 5Gy irradiation (IR) compared to p53
WT -expressing cells (Figure 1e ). Even without irradiation, a greater number of p53 ΔP and p53 − / − cells were observed to be in S-phase as compared to p53
WT -expressing cells, and exhibited more rapid growth than p53
WT cells (Figure 1f ). Irreversible cell cycle arrest was also compromised in p53
ΔP -expressing cells, as evidenced by an inability to undergo replicative-and oncogene-induced senescence (Figures 1g  and h (Figure 2a, Supplementary Figure 1A) . P53
ΔP -expressing cells exhibited a slightly enhanced sensitivity to intermediate doses of IR (12 Gy) as compared with p53 − / − cells, but higher doses (14 Gy) resulted in equally diminished survival in both cell types (Figure 2a , Supplementary Figure 1A ). P53 status was not important for long-term survival after treatment with Doxorubicin (0.75 μM and 1.0 μM) and Etoposide (25 μM and 50 μM).
Significantly however, p53 ΔP -expressing cells were highly resistant to the high dose of alkylating agent, Diazald (250 μM), surviving and proliferating better than either p53
WT -expressing or p53 MeG) adducts are less common, they are stable and will persist unless specifically repaired by the DNA repair protein MGMT. 32 We determined that MGMT gene expression was elevated following either IR (5 Gy) or Diazaldtreatment of p53 WT . 51, 52 We tested whether the difference in the levels of MGMT observed in p53
WT and p53
ΔP after IR may be due to a difference in the regulation and stability of p53 ΔP protein after damage. However, less p53
ΔP is stabilized after damage, compared with p53 WT , with a concomitant decrease in its negative regulator, MDM2, suggesting that there is not an increased turnover of p53 ΔP protein (Supplementary Figure 2A) . The difference in MGMT expression levels after IR between p53
WT -and p53 ΔP -cells may be due to the differences in cell survival between the cells.
Since the PRD is crucial for the efficient transcription function of p53, we were interested to determine if additional repair genes could also be induced upon IR treatment in Figure 1B) . To assess repair of Diazald-mediated damage by MGMT, levels of phosphorylated H2AX (γH2AX) were assessed at 3 h and 24 h after Diazald treatment by intracellular staining and subsequent flow cytometry. Briefly, cells were treated for 3 h with Diazald after which they were stained for γH2AX, or washed, and re-suspended in fresh media for an additional 24 h before staining for γH2AX. Compared with untreated cells, Diazald treatment for 3 h induced an equivalent shift in fluorescence (based on mean fluorescence intensity), indicating damaged DNA, in p53
WT , p53 ΔP and p53 − / − cells (Figure 3b ). Twentyfour hours after Diazald treatment, both p53
WT -and p53 ΔP -expressing cells showed a decrease in the levels of detectable γH2AX staining, comparable to those measured in untreated cells, indicating that repair of Diazald-mediated damage had occurred (Figure 3b ). By contrast, p53 − / − cells, which are unable to induce MGMT expression, maintained high levels of γH2AX staining after 24 h, consistent with an inability to repair Diazald-imposed DNA damage (Figure 3b ). DNA damage engages the DNA damage response pathway to engage p53, and elucidate an appropriate biological response to prevent the perpetuation of potentially tumorigenic mutations. 25 We therefore suggest that following DNA damage p53
ΔP can induce expression of the enzyme MGMT to mediate DNA repair and promote survival.
The role of MGMT in tumorigenesis following alkylation damage has already been characterized in p53-sufficient and -deficient mice. 53 To further explore this idea, we asked whether DNA damage-mediated MGMT induction promotes survival of mice after exposure to 4 Gy IR at p7. Survival after IR was examined in p53
WT , p53 ΔP and p53 − / − mice, and as expected, p53
− / − mice all died at roughly 3 months of age as a consequence of tumor formation (Figure 4a ). However, mice lacking the PRD (p53 ΔP ) showed significant survival after IR relative to p53 − / − mice, although with a slightly diminished survival when compared with p53 WT mice (Figure 4a) . Without MMR or apoptosis induction in p53
ΔP cells, any un-repaired Diazald-mediated damage would be propagated to daughter cells, resulting in genomic instability and aneuploidy. 54 We therefore examined the incidence of aneuploidy in p53
WT , p53
ΔP and p53 − / − MEF 72 h after 4 Gy IR, as assessed by flow cytometric analysis of 44n cell cycle distribution after propidium iodide staining (Figure 4b ). Compared with p53 WT cells, p53
ΔP and p53 − / − cells displayed more aneuploidy and increased genomic instability. We observed a further increase in the incidence of aneuploidy in p53 ΔP MEF lacking MGMT at 72 h following exposure to IR. This suggests that MGMT mediates some control of genomic stability in p53 ΔP cells. This however was not reflected in vivo, since there was no difference in the survival of mice lacking MGMT after IR at p7 (Figure 4a ).
MGMT silencing results in diminished repair and longterm survival in response to alkylating damage in cells expressing p53
ΔP
. We hypothesized that cells expressing p53
ΔP show superior survival after Diazald treatment because MGMT-mediated DNA repair is present and WT -expressing cells show reduced survival as compared to p53
ΔP cells, because they are able to undergo cell cycle arrest and apoptosis in response to alkylating damage (Supplementary Figure 2B) . A lack of p53 ensures that apoptosis, cell cycle arrest, and MGMT-mediated repair are not engaged upon alkylating DNA damage. Although in short-term assays p53
− / − cells are protected from apoptosis (Figure 1d) , their inability to survive and proliferate long term suggests that alternative non-apoptotic cell death mechanisms are likely engaged (Figure 2b ). It is possible that necrosis or mitotic catastrophe and subsequent death are engaged in these cells upon high dose Diazald treatment. We therefore hypothesized that silencing MGMT in p53
ΔP -expressing cells results in less survival after Diazald treatment, similar to that seen with p53 − / − cells. A lentiviral expression system was used to silence MGMT in p53 WT , p53
ΔP and p53 − / − transformed MEF and the efficiency of silencing was confirmed in all cell lines (Figure 5a,  Supplementary Figure 2C ). P53
ΔP and p53 − / − cells remained resistant to apoptosis induced by UV, IR and Diazald as compared to p53
WT -expressing cells, regardless of whether MGMT was silenced or not (Figure 5b ). However, when MGMT was silenced in p53
ΔP -expressing cells, Diazaldmediated damage could no longer be repaired (Figure 6a) . Importantly, we also saw that these cells could no longer survive and proliferate as compared to MGMT-expressing cells when treated with high dose Diazald (Figure 6e ). We also confirmed this result in MEFs isolated from p53 ΔP , MGMT − / − mice (Figure 6e ). In fact, these MGMT-silenced cells showed similar levels of survival and proliferation as compared to p53 − / − cells (Figure 6e ). Since p53 − / − cells do not express MGMT, it was not surprising that no difference in repair or survival after Diazald treatment was detected when MGMT was silenced or not (Figures 6a and e) . Diazaldtreatment of p53
WT cells in which MGMT was silenced showed less survival and proliferation in long-term assays (Figure 6e ). We noted that Diazald-induced damage appeared to be repaired by 24 h in p53
WT cells in which MGMT was silenced (Figure 6a ). Since p53
WT -expressing cells can undergo cell cycle arrest and apoptosis following the failure to repair damaged DNA (Supplementary Figure 2B) , we examined cell death in parallel to repair at the 24-h endpoint. Briefly, cells were treated for 3 h with Diazald, washed and cultured for an additional 18 h. We observed twice as much apoptosis in p53
WT cells lacking MGMT than any other cell line (Figure 6b ). We suggest that the apparent repair of DNA damage in p53
WT cells lacking MGMT is attributed to a small percentage of cells that failed to efficiently silence MGMT, maintained their repair function, and therefore escaped deletion by apoptosis or cell cycle arrest. To test this possibility, we overexpressed the antiapoptotic protein BCLxL in all cell lines sufficient or deficient for MGMT (Supplementary Figure 3B) . Diazald-induced cell death was completely inhibited in p53
WT cells sufficient or deficient for MGMT in which BCLxL was overexpressed (Figure 6c ). When Diazald-mediated apoptosis was inhibited by BCLxL expression, a population of cells clearly unable to repair alkylating damage was now visible in p53
WT cells lacking MGMT (Figure 6d ). P53
− / − cells were unable to repair damage in an MGMT-mediated manner, whereas p53
ΔP -expressing cells did so, unless MGMT was silenced (Figure 6a ). Interestingly, despite BCLxL protection from Diazald-mediated cell death in p53
WT -expressing cells, this did not confer significant long-term survival (Supplementary Figure 3C) . This may be due to cells undergoing permanent cell cycle arrest and/or alternative forms of cell death. To test this we silenced p21 levels in p53
WT cells overexpressing BCLxL, rendering these cells unable to engage cell cycle arrest or apoptosis (Supplementary Figure 3B) . These cells showed slightly better survival relative to p53 WT cells after alkylation, but did not phenocopy the survival seen in p53
ΔP cells (Supplementary Figure 3C) . This suggests that the response in p53
ΔP differs from that of p53 WT in additional ways to mediate survival after alkylation damage (Supplementary Figure 2B) .
MGMT expression in p53
− / − cells results in repair and survival in response to alkylating DNA damage. MGMT was overexpressed in p53 WT , p53 ΔP and p53 − / − cells ( Supplementary Fig 3A) , which were then subjected to Diazald treatment. We confirmed that MGMT expression did not alter sensitivity to Diazald-induced cell death in any of the cell lines (Figure 7a ). Importantly however, p53
− / − cells expressing MGMT were now capable of repairing Diazaldinduced DNA damage to a similar extent as that seen in p53
ΔP -expressing cells (Figure 7b ). Clonogenic assays confirmed that p53 − / − cells expressing MGMT showed increased survival and proliferation in response to Diazald treatment (Figures 6c and d) . Overexpression did not fully mimic the survival seen in p53 ΔP cells, probably because MGMT-mediated repair is stoichiometric such that survival is limited to the absolute amount of MGMT molecules per cell. 39 
Discussion
While some studies utilizing p53
ΔP mice suggested that cell cycle arrest is constrained but apoptosis remains functional, others suggest that the opposite is true. 11, 22 In the study described herein, we found that p53
ΔP cannot induce the expression of p21 and PUMA, and cells lacking the PRD are correspondingly deficient for apoptosis, cell cycle arrest, and senescence in response to DNA damage to a similar extent as seen in cells fully deficient for p53 function. Importantly however, unlike p53 − / − mice that develop spontaneous tumors, p53 ΔP mice rarely do, although some eventually succumbed to tumors with a median survival of approximately 400 days. 22, 55 We propose that biological functions of p53 are maintained in p53 ΔP , and must be engaged for tumor suppression.
We observed that p53 ΔP cells exhibited a differential longterm survival response to the alkylating agent Diazald, as compared to other DNA damaging agents. We determined that MGMT levels were induced in a p53-dependent manner in response to IR and Diazald, resulting in repair and survival of cells exposed to DNA damage. Importantly, our results corroborated those using genetic mouse models in which p53 showed an altered biological function. 8, 52 Cells from mice deficient for p21, PUMA, and NOXA displayed γ-irradiationinduced MGMT expression (among other repair genes), and could clear DNA lesions more rapidly than that observed in p53-deficient cells. 8 Additionally, gene expression profiles of oncogene-transduced HRAS-transduced MEF from the TAD mutant knockin (p53 L25Q, W26S ) mouse showed the induction of repair genes, including MGMT, and identified a p53 consensus-binding site in the MGMT promoter. 52 These studies suggested that MGMT is induced in a p53-dependent manner after DNA-damage or in response to oncogenes. Our studies show that in the absence of apoptosis, cell cycle arrest, and senescence, p53
ΔP can mediate cell survival through MGMT-mediated DNA repair. 
P53
− / − mice have an increased incidence of MNU-induced thymic lymphomas compared to MNU-treated wild-type mice, and overexpression of MGMT in the thymus of p53 +/ − mice significantly reduced this lymphoma incidence. 53 We found that whole body ionizing radiation (4 Gy) induced p53-mediated MGMT expression, facilitating DNA repair. While p53 − / − mice succumbed to tumors by 3 months, this was dramatically reduced in p53 ΔP mice after whole body irradiation. Other studies have shown some differences in the survival between p53
WT and p53 ΔP mice after whole body irradiation, which we also observed. 22, 55 It is feasible that the accumulating aneuploidy seen in p53 ΔP cells after irradiation may contribute to the difference in survival seen in p53 ΔP mice compared with p53 WT mice. Indeed, MEF lacking MGMT show increased aneuploidy after irradiation. 56 Both MEF cells and mice lacking the PRD, exhibit elevated aneuploidy in comparison to WT cells, under basal and irradiated conditions. 21, 55 Although MGMT-deficient mice fail to develop spontaneous tumors, they do exhibit an increased sensitivity to the genotoxic effects of methylating agents, and are highly vulnerable to tumors induced by alkylating agents as compared to WT mice. [42] [43] [44] [45] [46] We saw that contrary to our expectation, irradiated p53 ΔP mice lacking MGMT had a median survival of 250 days, failing to phenocopy p53 − / − mice. As p53 ΔP , MGMT − / − MEF showed higher levels of aneuploidy after irradiation than with p53 ΔP MEF, the extent to which aneuploidy may contribute to tumor induction remains unclear. Mice with defective mitotic checkpoint genes exhibit chromosomal changes in the absence of structural abnormalities, and despite the presence of aneuploidy, many of these mice are not predisposed to tumor formation. 57 A p53 mutant mouse (p53 3K KI) exhibits aneuploidy and genomic instability without spontaneous tumor formation. 58, 59 Therefore, chromosomal aneuploidy may be a consequence rather than a cause of deregulated cell growth.
We found that suppression or deletion of MGMT expression in p53
ΔP cells inhibited DNA repair and survival after alkylation damage and that its overexpression in p53-deficient cells facilitated DNA repair and conferred a survival advantage to the cells.
While p53-induced MGMT repair of DNA damage may be beneficial to prevent genomic instability and potential transformation of cells, its expression in established tumors may be detrimental to patient treatment and survival. Interestingly, many different types of cancers show promoter hypermethylation of MGMT, resulting in diminished MGMT expression. 60 The epigenetic silencing of the MGMT gene compromises DNA repair mechanisms and increases chemosensitivity, and has been shown to be a strong predictor of survival. [60] [61] [62] While MGMT mediated repair of DNA damage is crucial for survival of normal cells, a lack of MGMT induction in established tumors lacking p53 may actually be advantageous for overall patient survival. 
ER
tam were cultured in Dulbecco's modified essential medium (DMEM) (GIBCO, Waltham, MA, USA) supplemented with 10% dextran/charcoaltreated fetal bovine serum (dcFBS), L-glutamine, and penicillin. Primary MEF cells were transformed with H-RasG12V and 12S E1A (pWZL-Hygro-12S-E1A and pBabe-Puro-H-RasG12V) and cultured in DMEM supplemented with 10% FBS, 2 mM L-glutamine (GIBCO), and 100 U/ml penicillin-streptomycin (GIBCO), 1 mM sodium pyruvate (GIBCO), nonessential amino acids (GIBCO), and 55 μM β-mercaptoethanol (GIBCO).
Flow cytometry. For Annexin V staining, detached and adherent cells were harvested, washed, and re-suspended in Annexin V binding buffer (10 mM HEPES, 150 mM NaCl, 5 mM KCl, 1 mM MgCl 2 , and 1.8 mM CaCl 2 ) with Annexin V-APC or Annexin V-FITC (1/200; Caltag Laboratories, Waltham, MA, USA). For intracellular pH2AX staining, cells were treated with 100 μM Diazald (Sigma-Aldrich) for 3 h to assess damage, or treated with 100 μM Diazald for 3 h, washed twice with PBS and re-suspended in cell culture media (DMEM (GIBCO) supplemented with 10% FBS, 2 mM L-glutamine (GIBCO), to assess repair. Cells at 3 and 24 h were fixed and permeabilized using a cytofix/cytoperm kit according to the manufacturer's instructions (BD Biosciences, San Jose, CA, USA), and stained with Alexa Fluor-647 or Alexa Fluor-488 mouse anti-H2AX (pS139) antibody (1/200; BD Biosciences). Experiments were quantitated by flow cytometry, using FACScan and FACsCalibur systems (BD Biosciences) and FlowJo Collectors' Edition software (Tree Star, Ashland, USA). Flow cytometry data are represented as mean ± S.D. of three independent experiments, unless otherwise stated.
Cell growth, senescence and cell cycle analysis. Transformed MEF cells were plated at 5e4 and growth rate determined by viable cell count through trypan-blue dye exclusion. Cell cycle analysis was performed 24 h after 4 Gy y-irradiation using the BD Pharmingen BrdU Flow Kit staining procedure, and analyzed by flow cytometry and cell cycle analysis. Replicative senescence was examined in primary MEF after serial passaging. All primary MEF were plated at 2e5 and the number of days taken to reach 90% confluence was noted. Cells were subsequently split at a ratio of 1:4, which represents a population doubling of 2. Total cell number was then calculated based on the number of days taken to reach 90% confluence. Oncogene-induced senescence was examined in primary MEF cells plated at 1e3 and transduced with H-RasG12V. Puromycin-resistant clones were stained with methylene blue. To determine aneuplodidy, cells were treated with 4 Gy y-irradiation and 72 h later cells were lysed and stained using a hypotonic buffer (0.1% Triton-100, 0.1% sodium citrate, 50 μg/ml PI) for 30 min on ice to determine the fraction of nuclei with 44N DNA content by flow cytometry and cell cycle analysis.
Apoptosis and survival assays. Cells were treated for 18-24 h with the following DNA damaging agents: Actinomycin D (ActD; Sigma-Aldrich), Staurosporine (STS; Sigma-Aldrich), Etoposide (Sigma-Aldrich), Diazald (Sigma-Aldrich), y-irradiation, and UV irradiation (using a Stratagene UV cross-linker). Clonogenic survival was assessed after methylene blue staining of cells treated with y-irradiation, and UV irradiation, or after treatment with very high doses of DNA damaging agents; Staurosporine (3.5 and 10 μM), Etoposide (25 and 50 μM), Doxorubicin (Sigma-Aldrich, 0.75 and 1 μM) and Diazald (150 and 250 μM) for 3 h, washed and suspended in media.
